Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Arie Belldegrun

Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Overview

Career Highlights

Bellco Capital LLC
Two River Group Holdings LLC
Equinor ASA

RelSci Relationships

4947

Number of Boards

31

Birthday

1950

Age

71

Number of Awards

1

Contact Data

Trying to get in touch with Arie Belldegrun? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Relationships

View Relationship Details

RelSci Relationships are individuals Arie Belldegrun likely has professional access to. A relationship does not necessarily indicate a personal connection.

David M. Tanen

Co-Founder at Kirax Corporation

Relationship likelihood: Strong

Joshua Kazam

Co-Founder at VV Manager LLC

Relationship likelihood: Strong

David Chang

Venture Partner at Vida Ventures

Relationship likelihood: Strong

Rebecka Belldegrun

Founder at Bellco Capital LLC

Relationship likelihood: Strong

Owen Witte

Founding Director at University of California, Los Angeles - Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at David Geffen School of Medicine at UCLA

Relationship likelihood: Strong

Ran Nussbaum

Co-Founder & Managing Partner at Pontifax Management Co. Ltd.

Relationship likelihood: Strong

David Bonderman

Fund Advisor at TPG Global Advisors LLC

Relationship likelihood: Strong

Wendell Lim

Scientific Founder at Cell Design Labs, Inc.

Relationship likelihood: Strong

Arjun Goyal

Co-Founder & Managing Director at VV Manager LLC

Relationship likelihood: Strong

Stefan Vitorovic

Co-Founder & Managing Director at VV Manager LLC

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.

In The News

Business Wire

January 5, 2021

IconOVir Bio Raises $77 Million in Series A Financing to Develop Next-Generation Oncolytic Viruses to Treat Solid Tumors; Series A financing co-led by Nextech and Vida Ventures with participation from Two River Group, Bellco Capital, Polaris Partners, GV,

Commercial Property Executive

November 24, 2020

Tishman Speyer JV Raises $1B for Life Science Projects

peHUB

November 23, 2020

Breakthrough Properties racks up over $1bn for life science property fund

PR Newswire

November 11, 2020

SITC Announces Creation of Steven A. Rosenberg, MD, PhD, Endowed Scholars Fund Supporting Cancer Immunotherapy Research; Names Eric Tran, PhD, Inaugural Recipient; The Society for Immunotherapy of Cancer (SITC) is pleased to announce the creation of the S

New York Business Journal

September 14, 2020

Neogene Therapeutics raises $110M to develop neo-antigen T cell therapies for cancer

Paths to Arie Belldegrun

Potential Connections via
Relationship Science

You

Arie Belldegrun

Co-Founder & Senior Managing Director at VV Manager LLC

Family Members

Spouse

Rebecka Belldegrun

Founder at Bellco Capital LLC

Bellco Capital LLC provides investment advisory services. It focuses on deploying capital to create and support companies in life science, real estate, consumer products, media, and other sectors. The company was founded by Rebecka Belldegrun and Arie Belldegrun in 2003 and is headquartered in Los Angeles, CA.

Education

MD

Class of 1974

The Hebrew University Hadassah Medical School

Hadassah Medical School is a provider of learning medical training and research institute.

Memberships

Fellow

Current

American College of Surgeons

The primary exempt purpose is to improve the quality of care of the surgical patient through education and research.

Fellow

Current

The American Association of Genitourinary Surgeons

Member

Los Angeles Economy & Jobs Committee

Career History

Chairman, President & Chief Executive Officer

1988 - 1999

Equinor ASA

Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway; Exploration and Production International; Marketing, Midstream, and Processing; and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Marketing, Midstream, and Processing segment markets and trades of oil and gas commodities. The Other segment includes new energy solutions; global strategy and business development; technology; projects and drilling; and corporate staffs and services. The company was founded on September 18, 1972 and is headquartered in Stavanger, Norway.

Research Fellow in Surgical Oncology & Immunotherapy

Prior - 1988

National Cancer Institute

The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice.

Co-Founder

1996 - 2007

Agensys, Inc.

Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.

Boards & Committees

Executive Chairman of the Board

2017 - Current

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Chairman of the Board

2017 - Current

Kronos Bio, Inc.

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.

Chairman of the Board

2012 - Current

UroGen Pharma Ltd.

UroGen Pharma Ltd. is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. It has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. The firm's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's approved product, Jelmyto (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade non-muscle invasive bladder cancer, respectively. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.

Member of the Life Sciences & Management Advisory Board

Current

University of Pennsylvania

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Member, Board of Directors

Current

UCLA Institute of Urologic Oncology

Chairman-Molecular Biological Technology Committee

Prior

American Urological Association Education & Research, Inc.

American Urological Association Education & Research, Inc. operates a urologic association. It offers urological clinical care through education, research and the formulation of health care policy. The company was founded on February 22, 1902 and is headquartered in Linthicum, MD.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci

$2,500 - $4,999

2017

Henry Street Settlement, Inc.

Henry Street Settlement, Inc. delivers social services and art programs. The company was founded in 1893 and is headquartered in New York, NY.

$1,000 - $2,499

2016

United Friends of the Children

EMPOWERMENT OF CURRENT AND FORMER FOSTER YOUTH ON THEIR JOURNEY TO SELF-SUFFICIENCY.

$10K - $25K

2015

USC Shoah Foundation

USC Shoah Foundation, formerly Survivors of the Shoah Visual History Foundation, is a nonprofit organization dedicated to making audio-visual interviews with survivors and witnesses of the Holocaust (which in Hebrew is called the Shoah) and other genocides, a compelling voice for education and action. It was established by Steven Spielberg in 1994, one year after completing his Academy Award-winning film Schindler's List.

Political Donations

$2,500

2012

Lindsey Graham

Senator from South Carolina

$2,300

2007

Hillary Rodham Clinton

Former Senator from New York

$25K

2004

The Republican National Committee, Inc.

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

Transactions

Details Hidden

Vida Ventures LLC raised money in a private placement transaction

Details Hidden

Kite Pharma, Inc. raised money in a private placement transaction

Investments

Details Hidden

Kronos Bio, Inc.

Kronos Bio, Inc. is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA.

Details Hidden

Allogene Therapeutics, Inc.

Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell product candidates that are designed to target and kill cancer cells. Its engineered T cells are allogeneic, which are derived from healthy donors for intended use in any patient. The company was founded by Arie S. Belldegrun, David D. Chang, and Joshua A. Kazam in November 2017 and is headquartered in South San Francisco, CA.

Details Hidden

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a biopharmaceutical company, which focuses on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs. The company was founded in March 2000 and is headquartered in Tualatin, OR.

Public Holdings

Restricted data only for RelSci Professional users.

Awards & Honors

American Board of Urology - Board Certification in Pediatric Urology

Events

Speaker

Los Angeles, CA, United States

2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Other Affiliations

Arie Belldegrun is affiliated with Equinor ASA, National Cancer Institute, Agensys, Inc., Harvard University - Harvard Medical School, Weizmann Institute of Science, The Brigham & Women's Hospital, Inc., University of California, Los Angeles - David Geffen School of Medicine, Rabin Medical Center - Beilinson Hospital, Kite Pharma, Inc., Two River Group Holdings LLC, American Urological Association Education & Research, Inc., Allogene Therapeutics, Inc., VV Manager LLC, 8 Partners, UCLA Institute of Urologic Oncology, Bellco Capital LLC, Allogene Therapeutics, Inc., Kronos Bio, Inc., UroGen Pharma Ltd., Arno Therapeutics, Inc., Bellco Capital LLC, Two River Group Holdings LLC, Fosun Kite Biotechnology Co., Ltd., Cell Design Labs, Inc., Kite Pharma, Inc., Teva Pharmaceutical Industries Ltd., SonaCare Medical LLC, Capricor Therapeutics, Inc., Arno Therapeutics, Inc. (Inactive), Paramount Acquisition Corp., Chem Rx Corp. (Inactive), Email Real Estate.com, Inc., Talon Therapeutics, Inc., Janssen Oncology, Inc., Agensys, Inc., Equinor ASA, Heidelberg Pharma AG, Cougar Biotechnology, Inc. (Inactive), Roei Medical Devices Ltd., Bioscience for the State of California, My Size, Inc., Galil Medical Ltd., Technology Assessment Group, University of Pennsylvania, UCLA Institute of Urologic Oncology, American Urological Association Education & Research, Inc., American Urological Association, Inc., Bladder Cancer Advocacy Network

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Arie Belldegrun. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Arie Belldegrun's profile does not indicate a business or promotional relationship of any kind between RelSci and Arie Belldegrun.